{"id":863418,"date":"2025-06-24T16:35:34","date_gmt":"2025-06-24T20:35:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/avista-healthcare-partners-closes-continuation-fund-for-gcm\/"},"modified":"2025-06-24T16:35:34","modified_gmt":"2025-06-24T20:35:34","slug":"avista-healthcare-partners-closes-continuation-fund-for-gcm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/avista-healthcare-partners-closes-continuation-fund-for-gcm\/","title":{"rendered":"AVISTA HEALTHCARE PARTNERS CLOSES CONTINUATION FUND FOR GCM"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n Goldman Sachs Alternatives served as lead investor; additional investments from <\/b>
\n BlackRock Secondaries & Liquidity Solutions<\/b>\n <\/p>\n

\n
\n NEW YORK<\/span>
\n <\/span>, June 24, 2025<\/span><\/span> \/PRNewswire\/ — Avista Healthcare Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced the successful close of Avista Healthcare Partners CV II, L.P., a single-asset continuation fund for GCM, a leading outsourced manufacturer of complex precision components for high-growth medical technology end markets. The continuation fund, managed by Avista, is anchored by commitments from funds managed by Secondaries at Goldman Sachs Alternatives, with additional investments from funds managed by BlackRock Secondaries & Liquidity Solutions. The continuation fund includes substantial unfunded capital commitments to support acquisition opportunities and strategic investments for GCM.<\/p>\n

Since acquiring GCM in 2019, Avista has partnered with management to expand the company’s manufacturing and commercial capabilities through critical investments in technology, facilities and human capital while also growing the company’s customer base across attractive medical technology end markets. Since Avista’s acquisition, GCM has more than doubled its revenue.<\/p>\n

“We are pleased to provide our existing investors with the option for liquidity or continuing to participate in the value creation strategy we are successfully executing at GCM,” said Rob Girardi<\/span>, Partner at Avista Healthcare Partners. “We look forward to supporting GCM’s next phase of growth and expanding the company’s leading market position for the benefit of customers and all stakeholders.”<\/p>\n

“We are thrilled to continue our partnership with Avista,” said Seamus Meagher<\/span>, CEO of GCM. “The new capital and continued expertise of the Avista team will help us more quickly enhance our product offerings, expand our manufacturing capabilities, and achieve our next stage of growth.”<\/p>\n

“We are excited about the future prospects of GCM and the opportunity to partner with Avista in a transaction that provides existing investors a liquidity option while providing GCM additional duration and capital to take advantage of the compelling opportunity in the robotic surgical and other high-growth medical technology end markets,” said Brian Musto<\/span>, Managing Director in Vintage Strategies at Goldman Sachs Alternatives.<\/p>\n

\n Piper Sandler<\/span> served as exclusive financial advisor for the transaction and Ropes & Gray LLP served as legal counsel to Avista.<\/p>\n

\n About Avista Healthcare Partners
<\/b>Founded in 2005, Avista Healthcare Partners is a leading\u00a0New York-based private equity firm with over\u00a0$9 billion\u00a0invested in 50 growth-oriented healthcare businesses globally. Avista partners with businesses that feature strong management teams, stable cash flows and robust growth prospects \u2013 targeting healthcare product and technology businesses with clear scale potential across six sub-sectors experiencing strong tailwinds. The team is supported by a group of seasoned Strategic Executives enhancing the entire investment process through strategic insight, long-term value and sustainable businesses. For more information, visit\u00a0www.avistahealthcare.com<\/b><\/a>\u00a0or follow Avista on\u00a0LinkedIn<\/b><\/a>.<\/p>\n

\n About GCM
<\/b>Headquartered in\u00a0Union City, California<\/span>, with additional US facilities in\u00a0Chicago,\u00a0Atlanta\u00a0and Wilmington, NC<\/span>, GCM is a preferred supplier of complex manufacturing services to leading OEMs in medical technology end markets. GCM offers highly-engineered precision machining, fabrication and integration services as core service solutions. The company also provides value-added services to its customers including new product introduction, supply chain management and value engineering. For more information, please visit\u00a0www.gogcm.com<\/b><\/a>.<\/p>\n

\n About Secondaries at Goldman Sachs Alternatives
<\/b>Goldman Sachs (NYSE: GS) is one of the leading investors in alternatives globally, with over $500 billion<\/span> in assets and more than 30 years of experience. The business invests in the full spectrum of alternatives including private equity, growth equity, private credit, real estate, infrastructure, sustainability, and hedge funds. Clients access these solutions through direct strategies, customized partnerships, and open-architecture programs.<\/p>\n

The business is driven by a focus on partnership and shared success with its clients, seeking to deliver long-term investment performance drawing on its global network and deep expertise across industries and markets.<\/p>\n

The alternative investments platform is part of Goldman Sachs Asset Management, which delivers investment and advisory services across public and private markets for the world’s leading institutions, financial advisors and individuals. Goldman Sachs has approximately $3.2 trillion<\/span> in assets under supervision globally as of March 31, 2025<\/span>.<\/p>\n

Established in 1998, Secondaries at Goldman Sachs Asset Management has invested over $80 billion<\/span> since inception and has been a pioneer in the industry. The business provides liquidity, capital and partnering solutions to private market investors and managers worldwide across private equity strategies.<\/p>\n

Follow us on LinkedIn<\/a>.<\/p>\n

\n Contacts:
<\/b>
\n Daniel Yunger<\/span> \/ William Halliday<\/span>
Kekst CNC
daniel.yunger@kekstcnc.com<\/a> \/ william.halliday@kekstcnc.com<\/a><\/p>\n

\u00a0<\/p>\n

\n \"Cision\" View original content:https:\/\/www.prnewswire.com\/news-releases\/avista-healthcare-partners-closes-continuation-fund-for-gcm-302490198.html<\/a><\/p>\n

SOURCE Avista Healthcare Partners<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire Goldman Sachs Alternatives served as lead investor; additional investments from BlackRock Secondaries & Liquidity Solutions NEW YORK , June 24, 2025 \/PRNewswire\/ — Avista Healthcare Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced the successful close of Avista Healthcare Partners CV II, L.P., a single-asset continuation fund for GCM, a leading outsourced manufacturer of complex precision components for high-growth medical technology end markets. The continuation fund, managed by Avista, is anchored by commitments from funds managed by Secondaries at Goldman Sachs Alternatives, with additional investments from funds managed by BlackRock Secondaries & Liquidity Solutions. The continuation fund includes substantial unfunded capital commitments to support acquisition opportunities and strategic investments for GCM. Since acquiring … <\/p>\n

Continue reading “AVISTA HEALTHCARE PARTNERS CLOSES CONTINUATION FUND FOR GCM”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-863418","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAVISTA HEALTHCARE PARTNERS CLOSES CONTINUATION FUND FOR GCM - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/avista-healthcare-partners-closes-continuation-fund-for-gcm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AVISTA HEALTHCARE PARTNERS CLOSES CONTINUATION FUND FOR GCM - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Goldman Sachs Alternatives served as lead investor; additional investments from BlackRock Secondaries & Liquidity Solutions NEW YORK , June 24, 2025 \/PRNewswire\/ — Avista Healthcare Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced the successful close of Avista Healthcare Partners CV II, L.P., a single-asset continuation fund for GCM, a leading outsourced manufacturer of complex precision components for high-growth medical technology end markets. The continuation fund, managed by Avista, is anchored by commitments from funds managed by Secondaries at Goldman Sachs Alternatives, with additional investments from funds managed by BlackRock Secondaries & Liquidity Solutions. The continuation fund includes substantial unfunded capital commitments to support acquisition opportunities and strategic investments for GCM. Since acquiring … Continue reading "AVISTA HEALTHCARE PARTNERS CLOSES CONTINUATION FUND FOR GCM"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/avista-healthcare-partners-closes-continuation-fund-for-gcm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-24T20:35:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY17691&sd=2025-06-24\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avista-healthcare-partners-closes-continuation-fund-for-gcm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avista-healthcare-partners-closes-continuation-fund-for-gcm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AVISTA HEALTHCARE PARTNERS CLOSES CONTINUATION FUND FOR GCM\",\"datePublished\":\"2025-06-24T20:35:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avista-healthcare-partners-closes-continuation-fund-for-gcm\\\/\"},\"wordCount\":747,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avista-healthcare-partners-closes-continuation-fund-for-gcm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY17691&sd=2025-06-24\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avista-healthcare-partners-closes-continuation-fund-for-gcm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avista-healthcare-partners-closes-continuation-fund-for-gcm\\\/\",\"name\":\"AVISTA HEALTHCARE PARTNERS CLOSES CONTINUATION FUND FOR GCM - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avista-healthcare-partners-closes-continuation-fund-for-gcm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avista-healthcare-partners-closes-continuation-fund-for-gcm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY17691&sd=2025-06-24\",\"datePublished\":\"2025-06-24T20:35:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avista-healthcare-partners-closes-continuation-fund-for-gcm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avista-healthcare-partners-closes-continuation-fund-for-gcm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avista-healthcare-partners-closes-continuation-fund-for-gcm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY17691&sd=2025-06-24\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY17691&sd=2025-06-24\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avista-healthcare-partners-closes-continuation-fund-for-gcm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AVISTA HEALTHCARE PARTNERS CLOSES CONTINUATION FUND FOR GCM\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AVISTA HEALTHCARE PARTNERS CLOSES CONTINUATION FUND FOR GCM - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/avista-healthcare-partners-closes-continuation-fund-for-gcm\/","og_locale":"en_US","og_type":"article","og_title":"AVISTA HEALTHCARE PARTNERS CLOSES CONTINUATION FUND FOR GCM - Market Newsdesk","og_description":"PR Newswire Goldman Sachs Alternatives served as lead investor; additional investments from BlackRock Secondaries & Liquidity Solutions NEW YORK , June 24, 2025 \/PRNewswire\/ — Avista Healthcare Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced the successful close of Avista Healthcare Partners CV II, L.P., a single-asset continuation fund for GCM, a leading outsourced manufacturer of complex precision components for high-growth medical technology end markets. The continuation fund, managed by Avista, is anchored by commitments from funds managed by Secondaries at Goldman Sachs Alternatives, with additional investments from funds managed by BlackRock Secondaries & Liquidity Solutions. The continuation fund includes substantial unfunded capital commitments to support acquisition opportunities and strategic investments for GCM. Since acquiring … Continue reading \"AVISTA HEALTHCARE PARTNERS CLOSES CONTINUATION FUND FOR GCM\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/avista-healthcare-partners-closes-continuation-fund-for-gcm\/","og_site_name":"Market Newsdesk","article_published_time":"2025-06-24T20:35:34+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY17691&sd=2025-06-24","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avista-healthcare-partners-closes-continuation-fund-for-gcm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avista-healthcare-partners-closes-continuation-fund-for-gcm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AVISTA HEALTHCARE PARTNERS CLOSES CONTINUATION FUND FOR GCM","datePublished":"2025-06-24T20:35:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avista-healthcare-partners-closes-continuation-fund-for-gcm\/"},"wordCount":747,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avista-healthcare-partners-closes-continuation-fund-for-gcm\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY17691&sd=2025-06-24","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avista-healthcare-partners-closes-continuation-fund-for-gcm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/avista-healthcare-partners-closes-continuation-fund-for-gcm\/","name":"AVISTA HEALTHCARE PARTNERS CLOSES CONTINUATION FUND FOR GCM - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avista-healthcare-partners-closes-continuation-fund-for-gcm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avista-healthcare-partners-closes-continuation-fund-for-gcm\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY17691&sd=2025-06-24","datePublished":"2025-06-24T20:35:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avista-healthcare-partners-closes-continuation-fund-for-gcm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/avista-healthcare-partners-closes-continuation-fund-for-gcm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avista-healthcare-partners-closes-continuation-fund-for-gcm\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY17691&sd=2025-06-24","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY17691&sd=2025-06-24"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avista-healthcare-partners-closes-continuation-fund-for-gcm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AVISTA HEALTHCARE PARTNERS CLOSES CONTINUATION FUND FOR GCM"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/863418","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=863418"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/863418\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=863418"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=863418"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=863418"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}